Athira Pharma Inc (ATHA)

$2.05 0.005 (0.25%)
12:48 EDT ATHA Stock Quote Delayed 30 Minutes

Athira Pharma (ATHA) Stock Plunges 65% on Disappointing Drug Trial Results

By William White, InvestorPlace Writer
Athira Pharma (ATHA) stock is plummeting on Wednesday following the outcome of a Phase 2 clinical trial of fosgonimeton.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 77.82M
PE Ratio -1.35
EPS -1.51
Volume (Avg. Vol.) 29,558
Day's Range $2.04 - $2.10
52-Week Range $1.33 - $4.30
Dividend & Yield N/A (N/A)